Every bottle of blood product manufactured by us, from plasma donation to drug production and to patient use, undergoes a complex and rigorous manufacturing process. The selection of plasma donors is in accordance with the requirements of “Guidelines for Plasma Donors” issued by the National Health Commission of the PRC. The construction and management of plasmapheresis stations must comply with the “Basic Standards for Plasmapheresis Stations,” “Quality Management Specifications for Plasmapheresis Stations,” and “Technical Operating Procedures for Plasmapheresis Stations.” Each bottle of medicine can be traced back to the plasma donor and to the user, at the same time, the whole life-cycle management of the drugs complies with national GMP standards.